QNTM (Quantum BioPharma Ltd) חוב לטווח קצר להון
Quantum BioPharma Ltd (QNTM) is a small Canadian business undergoing a prolonged strategic shift, which has stripped it of its pricing power in the market. However, expansion potential is embedded in molecule patents that allow for the scaling of drug production via outsourcing. The price action on the chart confirms this, with the debt-to-equity ratio standing at 0.12. The holding company currently relies on external financing, as the development of cannabis-based medicines has yet to generate regular income.
פילוחים אנליטיים של חברת Quantum BioPharma Ltd
This indicator measures the proportion of short-term liabilities within the equity structure, reflecting the company's reliance on rapid debt financing and liquidity risk amid rising rates. Analyzing the ratio of short-term debt to equity on GURU.Markets allows for an assessment of how aggressively Quantum BioPharma Ltd (QNTM) is investing in AI search and neurodrug development by utilizing external credit lines to accelerate expansion.